MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan

MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today issued a Letter to Shareholders from the Company’s Board of Directors (the “Letter”). The Letter is…

MediPharm Showdown: Apollo Capital Pushes for Change

On our latest Trade To Black podcast, host Shadd Dales takes a closer look at the growing tension between MediPharm Labs (TSX: LABS) and one of its largest independent shareholders. Regan McGee, the CEO of Apollo Technology Capital Corporation, and John Fowler, industry veteran, join the show to break down their campaign to replace MediPharm’s current board. This episode is an important listen for anyone following cannabis stocks, board governan…